Adriana brings over 30 years of experience in the pharmaceutical industry, specializing in CMC (Chemistry, Manufacturing, and Controls) and Regulatory Affairs for the past two decades. She joined Inversago in 2020 and has since been promoted to Vice President, leading the CMC team through pivotal stages, including the initiation of clinical trials for our lead compound.

Before joining Inversago, Adriana served as a consultant at Icon, where she provided strategic CMC advice to small and medium-sized pharmaceutical companies, leading many projects to successful marketing approvals in the US, Canada, and Europe. Her extensive experience also includes managing post-approval changes and manufacturing site transfers. Adriana holds a BSc in Chemistry from Concordia University in Montreal.

• 

  Vice-President, CMC and Regulatory Affairs in Inversago Pharma

  Transformative therapies for the treatment of metabolic and fibrotic diseases